| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |